Opaleye Management reported a 13.07% stake in Grace Therapeutics GRCE · 2,748,392 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 13.07%
Last report: First report
Shares held: 2,748,392 sh
Class: Common Stock, par value $0.0001 per share
Stock: Grace Therapeutics GRCE
Holder: Opaleye Management
Event date: 26/08/05
Filed: 26/08/07

First 5%+ report · 13.07% stake

Grace Therapeutics trades, last 26 weeks

What else happened in Grace Therapeutics around then

Filed or reported within 30 days of the trade day · 07/06~09/04

Opaleye Management's other 5% stake reports

Opaleye Management
5% stakeQ32 Bio
5% stake
Q32 Bio
QTTB
5.49% stake
931,000 sh
5.49% stake
Filed 07/31
Opaleye Management
5% stakeSanuwave Health
5% stake
Sanuwave Health
SNWV
3.6% stake
309,948 sh
3.6% stake
Filed 07/31
Opaleye Management
5% stakePasithea Therapeutics
5% stake
Pasithea Therapeutics
KTTA
6.14% stake
2,050,000 sh
6.14% stake
Filed 07/31
Opaleye Management
5% stakeHarrow
5% stake
Harrow
HROW
6.44% stake
2,400,000 sh
6.44% stake
Filed 07/31
Opaleye Management
5% stakeGossamer Bio
5% stake
Gossamer Bio
GOSS
5.1% stake
24,942,565 sh
5.1% stake
Filed 07/29